lactoferrin and Pharyngitis

lactoferrin has been researched along with Pharyngitis* in 2 studies

Trials

1 trial(s) available for lactoferrin and Pharyngitis

ArticleYear
Anti-invasive activity of bovine lactoferrin towards group A streptococci.
    Biochemistry and cell biology = Biochimie et biologie cellulaire, 2002, Volume: 80, Issue:1

    Group A streptococci (GAS) are able to invade cultured epithelial and endothelial cells without evidence of intracellular replication. GAS, like other facultative intracellular bacterial pathogens, evolved such ability to enter and to survive within host cells avoiding the host defences, and bacterial intracellular survival could explain the recurrence of infections. We report here that 1 mg bovine lactoferrin (bLf)/mL significantly hindered the in vitro invasion of cultured epithelial cells by GAS isolated from patients suffering from pharyngitis and completely inhibited the invasiveness of GAS pretreated with subinhibiting concentrations of erythromycin or ampicillin. One milligram of bLf per millilitre was also able to increase the number of epithelial cells undergoing apoptosis following GAS invasion, although the number of intracellular GAS in the presence of bLf decreased by about 10-fold. The ability of bLf to decrease GAS invasion was confirmed by an in vivo trial carried out on 12 children suffering from pharyngitis and already scheduled for tonsillectomy. In tonsil specimens from children treated for 15 days before tonsillectomy with both oral erythromycin (500 mg t.i.d. (three times daily)) and bLf gargles (100 mg t.i.d.), a lower number of intracellular GAS was found in comparison with that retrieved in tonsil specimens from children treated with erythromycin alone (500 mg t.i.d.).

    Topics: Animals; Anti-Bacterial Agents; Apoptosis; Cattle; Cell Division; Child; Erythromycin; HeLa Cells; Humans; Lactoferrin; Palatine Tonsil; Pharyngitis; Streptococcus

2002

Other Studies

1 other study(ies) available for lactoferrin and Pharyngitis

ArticleYear
Causes for massive bacterial colonization on mucosal membranes during infectious mononucleosis: implications for acute otitis media.
    International journal of pediatric otorhinolaryngology, 2002, Sep-24, Volume: 65, Issue:3

    A common complication of virus-induced upper respiratory tract infections is acute otitis media caused by bacterial pathogens. Simultaneously, increased bacterial colonization in the nasopharynx occurs. Our intention in this study was to identify the causes of this increased colonization of bacteria by evaluating their coating with the antibacterial substances lysozyme, lactoferrin and immunoglobulins IgG, S-IgA and IgM and their ability to penetrate epithelial cells during infectious mononucleosis (IM) caused by Epstein-Barr virus.. Cellular samples were collected from the oropharynx of 21 patients (16 males, five females; age range 10-21 years) with current IM. An immunocytochemical assay using gold-labelled antiserum to human lysozyme, lactoferrin, IgG, S-IgA and IgM followed by gold particle and epithelial cell tracing in the transmission electron microscope.. A significant reduction in bacterial coating with IgG (P<0.05) and S-IgA (P<0.01) was noted, whereas there was a significant increase in coating with lactoferrin (P<0.01) and IgM (P<0.01). No significant change in lysozyme coating of the bacteria was noted, compared with healthy controls. Bacterial penetration into epithelial cells was seen particularly in patients culture-positive for beta-haemolytic streptococci.. Reduced bacterial coating with IgG and S-IgA immunoglobulins, combined with bacterial penetration into epithelial cells, may exacerbate the bacterial colonization on oropharyngeal mucosal membranes observed during IM.

    Topics: Acute Disease; Adolescent; Adult; Case-Control Studies; Child; Data Interpretation, Statistical; Epithelial Cells; Female; Herpesvirus 4, Human; Humans; Immunity, Mucosal; Immunoglobulin A, Secretory; Immunoglobulin G; Immunoglobulin M; Infectious Mononucleosis; Lactoferrin; Male; Microscopy, Electron; Muramidase; Nasal Mucosa; Nasopharynx; Otitis Media; Pharyngitis

2002